| Sentara Health Plans Avalon | M2168: Proteogenomic Testing of Individuals with Cancer | 2026-05-01 |
| Sentara Health Plans Avalon | M2175: Minimal Residual Disease (MRD) | 2026-05-01 |
| Sentara Health Plans Avalon | M2176: Testing for Developmental Delay | 2026-05-01 |
| Sentara Health Plans Avalon | M2178: Microsatellite Instability and Tumor Mutational Burden Testing | 2026-05-01 |
| Sentara Health Plans Avalon | P2018: Immunohistochemistry | 2026-05-01 |
| Sentara Health Plans Avalon | R2162: Laboratory Procedures Reimbursement Policy | 2026-05-01 |
| Ambetter Health Louisiana Clinical | Allogeneic Hematopoietic Progenitor Cell Therapy | 2026-05-01 |
| BCBS Iowa Medical Policies | Compression Devices in the Home Setting | 2026-05-01 |
| Ambetter Health Georgia Clinical | Behavioral Health Documentation Requirements | 2026-05-01 |
| Ambetter Health Mississippi Magnolia Clinical | Total Artificial Heart | 2026-05-01 |